Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson's disease patients.
Antonini A, Abbruzzese G, Berardelli A, Modugno N, Stroppa I, Tamma F, Sensi M, Mancini F, Cossu G, Stefani A, Tambasco N, Tessitore A, Fabbrini G, Pontieri FE, Solla P, Bentivoglio AR, Comi C, Minafra B, Riboldazzi G, Melchionda D, Martino T, Lopiano L. Antonini A, et al. Among authors: riboldazzi g. J Neural Transm (Vienna). 2020 Jun;127(6):881-891. doi: 10.1007/s00702-020-02175-1. Epub 2020 Mar 24. J Neural Transm (Vienna). 2020. PMID: 32212015
Motor complications of Parkinson's disease.
Martignoni E, Riboldazzi G, Calandrella D, Riva N. Martignoni E, et al. Among authors: riboldazzi g. Neurol Sci. 2003 May;24 Suppl 1:S27-9. doi: 10.1007/s100720300033. Neurol Sci. 2003. PMID: 12774208 Review.
Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson's disease.
Blandini F, Nappi G, Fancellu R, Mangiagalli A, Samuele A, Riboldazzi G, Calandrella D, Pacchetti C, Bono G, Martignoni E. Blandini F, et al. Among authors: riboldazzi g. J Neural Transm (Vienna). 2003 Aug;110(8):911-22. doi: 10.1007/s00702-003-0004-z. J Neural Transm (Vienna). 2003. PMID: 12898346
Reproductive life milestones in women with Parkinson's disease.
Martignoni E, Nappi RE, Citterio A, Calandrella D, Zangaglia R, Mancini F, Corengia E, Riboldazzi G, Polatti F, Nappi G. Martignoni E, et al. Among authors: riboldazzi g. Funct Neurol. 2003 Oct-Dec;18(4):211-7. Funct Neurol. 2003. PMID: 15055746
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson's disease. The effect of dopaminergic treatment.
Blandini F, Cosentino M, Mangiagalli A, Marino F, Samuele A, Rasini E, Fancellu R, Tassorelli C, Pacchetti C, Martignoni E, Riboldazzi G, Calandrella D, Lecchini S, Frigo G, Nappi G. Blandini F, et al. Among authors: riboldazzi g. J Neural Transm (Vienna). 2004 Aug;111(8):1017-30. doi: 10.1007/s00702-004-0123-1. Epub 2004 Mar 19. J Neural Transm (Vienna). 2004. PMID: 15254790 Clinical Trial.
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.
Di Fonzo A, Tassorelli C, De Mari M, Chien HF, Ferreira J, Rohé CF, Riboldazzi G, Antonini A, Albani G, Mauro A, Marconi R, Abbruzzese G, Lopiano L, Fincati E, Guidi M, Marini P, Stocchi F, Onofrj M, Toni V, Tinazzi M, Fabbrini G, Lamberti P, Vanacore N, Meco G, Leitner P, Uitti RJ, Wszolek ZK, Gasser T, Simons EJ, Breedveld GJ, Goldwurm S, Pezzoli G, Sampaio C, Barbosa E, Martignoni E, Oostra BA, Bonifati V; Italian Parkinson's Genetics Network. Di Fonzo A, et al. Among authors: riboldazzi g. Eur J Hum Genet. 2006 Mar;14(3):322-31. doi: 10.1038/sj.ejhg.5201539. Eur J Hum Genet. 2006. PMID: 16333314
GIGYF2 mutations are not a frequent cause of familial Parkinson's disease.
Di Fonzo A, Fabrizio E, Thomas A, Fincati E, Marconi R, Tinazzi M, Breedveld GJ, Simons EJ, Chien HF, Ferreira JJ, Horstink MW, Abbruzzese G, Borroni B, Cossu G, Dalla Libera A, Fabbrini G, Guidi M, De Mari M, Lopiano L, Martignoni E, Marini P, Onofrj M, Padovani A, Stocchi F, Toni V, Sampaio C, Barbosa ER, Meco G; Italian Parkinson Genetics Network; Oostra BA, Bonifati V. Di Fonzo A, et al. Parkinsonism Relat Disord. 2009 Nov;15(9):703-5. doi: 10.1016/j.parkreldis.2009.05.001. Epub 2009 May 31. Parkinsonism Relat Disord. 2009. PMID: 19482505
Effectiveness of intensive inpatient rehabilitation treatment on disease progression in parkinsonian patients: a randomized controlled trial with 1-year follow-up.
Frazzitta G, Bertotti G, Riboldazzi G, Turla M, Uccellini D, Boveri N, Guaglio G, Perini M, Comi C, Balbi P, Maestri R. Frazzitta G, et al. Among authors: riboldazzi g. Neurorehabil Neural Repair. 2012 Feb;26(2):144-50. doi: 10.1177/1545968311416990. Epub 2011 Aug 15. Neurorehabil Neural Repair. 2012. PMID: 21844282 Clinical Trial.
Adherence to anti-Parkinson drug therapy in the "REASON" sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the "Morisky Medical Adherence Scale-8 items".
Fabbrini G, Abbruzzese G, Barone P, Antonini A, Tinazzi M, Castegnaro G, Rizzoli S, Morisky DE, Lessi P, Ceravolo R; REASON study group. Fabbrini G, et al. Neurol Sci. 2013 Nov;34(11):2015-22. doi: 10.1007/s10072-013-1438-1. Epub 2013 Jun 1. Neurol Sci. 2013. PMID: 23728715
52 results